ETI
TEVA icon

Enterprise Trust & Investment’s Teva Pharmaceuticals TEVA Stock Holding History

Enterprise Trust & Investment’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$1K – 370
2022
Q1 		$1K Hold
100
– – ﹤0.01% 194
2021
Q4 		$1K Buy
+100
New +$903 ﹤0.01% 205

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Enterprise Trust & Investment's TEVA Position: Q2 2022 in Review

Enterprise Trust & Investment sold out of Teva Pharmaceuticals (TEVA) in Q2 2022, closing a stake of 100 shares — an estimated $1K sold.

Enterprise Trust & Investment first reported a position in TEVA in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2022.

  • Enterprise Trust & Investment reported no remaining Teva Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Enterprise Trust & Investment sold 100 Teva Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • Enterprise Trust & Investment first reported a position in Teva Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Enterprise Trust & Investment's Teva Pharmaceuticals position peaked at $1K in Q1 2022.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.